| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/14/2006 | WO2006121979A3 Modified-release pharmaceutical compositions |
| 12/14/2006 | WO2006116733A3 Protein kinase inhibitors |
| 12/14/2006 | WO2006116596A3 Micronized tanaproget and compostions containing same |
| 12/14/2006 | WO2006116583A3 Compositions comprising a polymerized benzimidazole and a buffering agent and methods of using same |
| 12/14/2006 | WO2006116514A3 Micronized tanaproget, compositions, and methods of preparing the same |
| 12/14/2006 | WO2006116498A3 Purified form of tanaproget |
| 12/14/2006 | WO2006115987A3 Use of a clobetasol spray formulation to treat psoriasis |
| 12/14/2006 | WO2006115835A3 Benzothiophene hydroxamic acid derivatives |
| 12/14/2006 | WO2006115412A3 Nutrition with lipids and non-digestible saccharides |
| 12/14/2006 | WO2006113981A3 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 12/14/2006 | WO2006113842A3 Method and composition for inhibiting cell proliferation and angiogenesis |
| 12/14/2006 | WO2006113571A3 Substituted cyclopentanones for treating inflammatory bowel disease |
| 12/14/2006 | WO2006112705A3 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure. |
| 12/14/2006 | WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 12/14/2006 | WO2006108424A3 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin |
| 12/14/2006 | WO2006107948A3 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
| 12/14/2006 | WO2006107062A3 Benzimidazole derivative and use as angiotensin ii antagonist |
| 12/14/2006 | WO2006105670A8 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| 12/14/2006 | WO2006102684A3 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
| 12/14/2006 | WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors |
| 12/14/2006 | WO2006101977A3 Pyrimidine compounds and methods of use |
| 12/14/2006 | WO2006100225A3 Benzoic acid ester compounds, compositions, uses and methods related thereto |
| 12/14/2006 | WO2006096970A8 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 12/14/2006 | WO2006095363A3 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| 12/14/2006 | WO2006095139A3 Cancer treatment using specific 3,6,9-substituted acridines |
| 12/14/2006 | WO2006094917A3 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |
| 12/14/2006 | WO2006094246A3 N-arylmethyl benzamide sirtuin modulators |
| 12/14/2006 | WO2006093774A3 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 12/14/2006 | WO2006092727A9 Process for the production of calcium compositions in a continuous fluid bed |
| 12/14/2006 | WO2006091544A3 Methods and compositions for modulating calcium channels |
| 12/14/2006 | WO2006091442A3 Transdermal systems having control delivery system |
| 12/14/2006 | WO2006089211A3 Combat/training antioxidant micronutrient formulation and method of administration |
| 12/14/2006 | WO2006089177A3 Isoxazole combretastin derivatives for the treatment of disorders |
| 12/14/2006 | WO2006087752A8 Cationic lipids for the transfection of nucleic acids |
| 12/14/2006 | WO2006086488A3 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses |
| 12/14/2006 | WO2006085302A3 Composition for treatment of skin disorders |
| 12/14/2006 | WO2006084911A3 Improved device for application of medicaments, manufacturing method therefor, and method of treatment |
| 12/14/2006 | WO2006084200A3 Nitroxides for use in treating or preventing cardiovascular disease |
| 12/14/2006 | WO2006084058A3 Method for treating gefitinib resistant cancer |
| 12/14/2006 | WO2006083678A3 β-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS |
| 12/14/2006 | WO2006083328A3 Biologically active surfaces and methods of their use |
| 12/14/2006 | WO2006082409A3 Tricyclic cytoprotective compounds |
| 12/14/2006 | WO2006081554A3 Phenyl-substituted pyrrolidones |
| 12/14/2006 | WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 12/14/2006 | WO2006081289A3 Antibacterial agents |
| 12/14/2006 | WO2006078925A3 A tetracycline metal complex in a solid dosage form |
| 12/14/2006 | WO2006078274A3 Beta-peptides |
| 12/14/2006 | WO2006075932A3 Remedy to accelerate healing of wound and burn |
| 12/14/2006 | WO2006075095A3 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer |
| 12/14/2006 | WO2006072636A3 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
| 12/14/2006 | WO2006071912A3 A method for treating or preventing pruritic and neurogenic skin disorders by applying sertaconazole |
| 12/14/2006 | WO2006069326A3 Polyethylene glycolated superoxide dismutase mimetics |
| 12/14/2006 | WO2006068668A3 Compositions and methods for modulating calcium flux, glucose homeostasis and apoptosis |
| 12/14/2006 | WO2006066267A3 Cancer treatment method |
| 12/14/2006 | WO2006066079A3 Pyridazinone compounds |
| 12/14/2006 | WO2006053766A8 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol |
| 12/14/2006 | WO2006050457A3 Methods and compositions for treating chronic lymphocytic leukemia |
| 12/14/2006 | WO2006049764A3 Methods of making 2,6-diaryl piperidine derivatives |
| 12/14/2006 | WO2006034473A3 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 12/14/2006 | WO2006034219A3 Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums |
| 12/14/2006 | WO2006031376A3 Use of antioxidants for treating degenerative disc disease |
| 12/14/2006 | WO2006017505A3 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 12/14/2006 | WO2006014913A3 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| 12/14/2006 | WO2006014787A3 Compositions containing policosanol and b vitamins and their pharmaceutical uses |
| 12/14/2006 | WO2005123074A9 Use of a compound in the treatment of sleep disorders |
| 12/14/2006 | WO2005120643A8 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
| 12/14/2006 | WO2005120497A3 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 12/14/2006 | WO2005113571A3 Methods for the delivery of oligomeric compounds |
| 12/14/2006 | WO2005112648A8 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake |
| 12/14/2006 | WO2005110428A3 Resistance-repellent retroviral protease inhibitors |
| 12/14/2006 | WO2005102338A8 Method of treating neuropathic pain using a crth2 receptor antagonist |
| 12/14/2006 | WO2005100322A8 Sulphur-linked imidazole compounds for the treament of hiv |
| 12/14/2006 | WO2005079752A3 Controlled release pharmaceutical compositions with improved bioavailability |
| 12/14/2006 | WO2005075425A3 Substituted bisarylurea derivatives as kinase inhibitors |
| 12/14/2006 | WO2005067627A3 Cosmetic composition and method for retarding hair growth |
| 12/14/2006 | WO2005053644A8 A medical product comprising tiotropium in a moisture-proof container |
| 12/14/2006 | WO2004093794A3 Antimicrobial medical articles containing a combination of anti-infective compounds, octoxyclycerin, salicylic acid, and sesquiterpenoids |
| 12/14/2006 | WO2001022972A9 Immunostimulatory nucleic acids |
| 12/14/2006 | US20060282909 Methods and compositions for therapeutic intervention in cardiac hypertrophy |
| 12/14/2006 | US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/14/2006 | US20060281902 Human signal peptide-containing proteins |
| 12/14/2006 | US20060281887 (Meth)acrylate copolymer for use as medical carrier |
| 12/14/2006 | US20060281822 Treatment and prevention of elevated homocysteine |
| 12/14/2006 | US20060281821 Retinoid replacements and opsin agonists and methods for the use thereof |
| 12/14/2006 | US20060281820 Lfa-1 inhibitors and use thereof |
| 12/14/2006 | US20060281819 Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processing |
| 12/14/2006 | US20060281818 Method for treating mucosal disorders |
| 12/14/2006 | US20060281817 Treatment for neurodegenerative diseases |
| 12/14/2006 | US20060281816 Pregabalin free of lactam and a process for preparation thereof |
| 12/14/2006 | US20060281815 Conjugated linolenic acids and methods of preparation and purification and uses thereof |
| 12/14/2006 | US20060281814 Conjugated linolenic acids and methods for commerical preparation and purification |
| 12/14/2006 | US20060281813 Methods of treating hyperproliferative cell disorders |
| 12/14/2006 | US20060281812 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine tartrate |
| 12/14/2006 | US20060281811 Synthesis of taxol enhancers |
| 12/14/2006 | US20060281810 Novel anthranilic acid derivatives |
| 12/14/2006 | US20060281809 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 12/14/2006 | US20060281808 Sovlent extraction of quassin and neoquassin with ethanol, evaporation, washing with hexane, saturation with sodium chloride, extraction with ethyl acetate, crystallization, separating mother liquor by column chromatography, crystallizing any additional quassinoids; nontoxic |
| 12/14/2006 | US20060281807 Quassinoid compositions for the treatment of cancer and other proliferative diseases |
| 12/14/2006 | US20060281806 Treatment and inhibition of disease conditions using flexible heteroarotinoids |
| 12/14/2006 | US20060281805 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |